IP Library Granted Patent US 10,004,819
Granted Patent B2
US 10,004,819 · App. 14/300,462 · Granted Jun 26, 2018

Tissue allograft sterilization method

Inventor: Theodore I Malinin (Key Biscayne, FL)
Assignee: Vivex Biomedical, Inc.
A61L2/0088A01N1/0215A01N1/0289A01N47/44A01N59/00A61L27/3687A61L27/3691A61L2202/21A61L2430/02A61L2430/06A61L2430/34Y10T83/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,819
App. No.
14/300,462
Granted
Jun 26, 2018
Kind
B2
Abstract

The invention is a novel method of sterilizing bone and soft tissues intended for human transplantation. In one embodiment the process includes steps of subjecting transplants to high hydrostatic pressures of aqueous fluid to which chlorhexidine gluconate or similar sterilizing chemicals have been added.

Claims (20)

1. A method for producing a bone graft suitable for transplantation into a human from cadaver bone, the method comprising the steps of:

(a) initially washing the cadaver bone;

(b) exposing the washed cadaver bone to a jet stream from a water jet system, which has been adjusted below a cutting capacity of the water jet system, to form a jet stream-washed bone graft;

(c) delivery of one or more sterilizing solutions containing chlorhexidine gluconate, Dakin solution, chloramineT and/or other solutions generating hypochlorous acid to the jet stream-washed bone graft using a high pressure chamber having a high hydrostatic pressure so as to achieve microbial inactivation of the bone graft;

(d) re-washing the microbial inactivated bone graft under high hydrostatic pressure in the range of 100-600 MPa to remove residuals of the one or more sterilizing solutions; and

(e) immersing the re-washed bone graft in Dakin solution or other solution producing hypochlorous acid at normal atmospheric pressure.

2. The method of claim 1 , wherein in step (c) the bone graft is treated with a 0.5% to 5% solution of chlorhexidine gluconate.

3. The method of claim 1 , further comprising washing the bone graft with distilled water after step (e).

4. The method of claim 1 , further comprising washing the bone graft with distilled water after step (e).

5. The method of claim 1 , wherein in step (c) the sterilizing solution contains chlorhexidine gluconate and the high hydrostatic pressure is in the range of 50-400 MPa.

6. The method of claim 5 , further comprising washing the bone graft with distilled water after step (e).

7. The method of claim 5 , further comprising washing the bone graft with distilled water after step (e).

8. The method of claim 1 , wherein in step (c) the sterilizing solution contains Dakin solution and/or other compounds which produce hypochlorous acid under high hydrostatic pressure, and wherein the high hydrostatic pressure is in the range of 50-400 MPa.

9. The method of claim 8 , further comprising washing the bone graft with distilled water after step (e).

10. The method of claim 8 , further comprising washing the bone graft with distilled water after step (e).

11. The method of claim 1 , wherein in step (b) the jet stream from the water jet system comprises a jet stream of sterile water or sterile physiologic saline.

12. The method of claim 11 , wherein in step (b) the jet steam comprises sterile physiologic saline.

13. The method of claim 11 , further comprising cutting the prewashed bone with a high pressure focused water jet stream, the high pressure being adjusted to cut bone in the range of 100 to 600 MPa.

14. The method of claim 1 , wherein in the step (d) the re-washing under high hydrostatic comprises re-washing with oxygenated or carbonated solutions, under high pressure in the range of 100 to 600 MPa.

15. The method of claim 14 wherein the solutions are carbonated solutions.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2022
From: BANKUNITED, N.A.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 061333/0853 →
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
RELEASE OF SECURITY INTEREST Recorded Dec 12, 2019
From: HERITAGE BANK OF COMMERCE
To: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
Reel/Frame 051282/0653 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 11, 2019
From: VIVEX BIOLOGICS GROUP, INC.
To: BANKUNITED, N.A.
Reel/Frame 051260/0064 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 050079/0179 →
CHANGE OF NAME Recorded Aug 16, 2019
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 050079/0225 →
SECURITY INTEREST Recorded Mar 19, 2019
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 048629/0691 →
SECURITY INTEREST Recorded Feb 22, 2017
From: VIVEX BIOMEDICAL, INC.; UMTB BIOMEDICAL, INC.; ADVANCED NUMED TECHNOLOGIES, LTD.; VIVEX BIOMEDICAL INTERNATIONAL, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 041782/0452 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: MALININ, THEODORE I
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 033065/0182 →
Continuity (1)
Related Publication 20150352235A1 · Dec 10, 2015